Search
Filter Results
Displaying 501–510 of 749 for “retinal diseases”
-
Aug 7, 2017
Sight and Song: The Christian Guardino Story
Beacon StoriesChristian Guardino has been singing for as long as he can remember; it’s the seeing that is something new.
-
Jun 1, 2017
Valproic Acid's Effect Too Small in One-Year Clinical Trial
Research NewsWhile a therapy for adRP will not emerge from the clinical trial, study investigators advanced development of a new outcome measure known as EZ Area to quickly and accurately evaluate potential therapies for RP in human studies.
-
Jun 27, 2015
VISIONS 2015 — Dr. José Sahel Receives Foundation's Most Prestigious Research Honor
Research NewsFor those of us supporting the drive for vision-saving treatments and cures, he’s exactly the type of person we want on our team.
-
Feb 3, 2015
A Stem-Cells Video for Kids (and Newbies of All Ages)
Research NewsBiology and genetics can be difficult to understand for even an educated adult, so when something kid-friendly is produced, especially a video, we are eager to share it.
-
Dec 12, 2013
Foundation Chairman, Gordon Gund, Interviewed on Forbes.com
Beacon StoriesThe driving force behind the Foundation’s considerable advances covers those, as well as other compelling subjects, during a 27-minute Q&A.
-
May 30, 2012
Beacon StoriesBrooke James has had more than a glimpse of what it means to be blind in certain parts of the world. And she can assure you, it’s scary.
-
Sep 25, 2020
ProQR Announces Virtual Presentations at Scientific Conferences
ResourceProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual presentations at the Ophthalmology Futures Retina Forum, European Society of Retina Specialists (Euretina) congress and the Annual Meeting of the American Academy of Optometry (AAOpt).
-
- May 13, 2027
- 5:30 p.m. (EDT)
- 409 E 59th St, New York, NY 10022
Signature EventNew York Night for Sight is an unforgettable evening of dining, entertainment, and philanthropy benefiting the Foundation Fighting Blindness and its mission to find treatments and cures for blinding diseases.
-
Oct 8, 2021
Foundation Hosts Workshop on USH1B Research and Therapy Development
Research NewsEmerging dual-vector gene therapies to address current cargo-size limitations were highlighted during the meeting.
-
Jul 24, 2017
FFB-Funded Scientists Report on Nine Promising Translational Research Efforts
Research NewsThe Foundation Fighting Blindness has taken the translational challenge head on by investing more than $75 million in therapy-development projects with strong clinical-trial potential through its Translational Research Acceleration Program (TRAP), which includes Gund-Harrington Scholar Awards.